Clinical Chronopharmacology in the Elderly

References

• Bruguerolle B. Chronopharmacokinetics: Current status. Clin. Pharmacokinet 1998a; 35: 83–94
   PubMed Web of Science ®Google Scholar
• Bruguerolle B. General concepts and new trends in chronopharmacology. Biological Clocks: Mechanisms and Applications, Y Touitou. Elsevier, Paris 1998b; 437–443
   Google Scholar
• Bruguerolle B, Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 2002; 25: 194–201
   PubMed Web of Science ®Google Scholar
• Bruguerolle B, Arnaud C, Bouvenot G. Variations circadiennes de l'alpha 1 glycoproteine acide (orosomucoide). Conséquences thérapeutiques? Etude préliminaire. Sem. Hop. 1984; 60: 2916–2917
   Google Scholar
• Bruguerolle B, Barbeau G, Belanger P, Labrecque G. Chronokinetics of indomethacin in elderly subjects. Annu. Rev. Chronopharmacol. 1986; 3: 425–428
   Google Scholar
• Bruguerolle B, Bouvenot G, Bartolin R, Manolis J. Digoxin chronokinetics in elderly patients. Thérapie 1988; 43: 251–253
   PubMed Web of Science ®Google Scholar
• Bruguerolle B, Arnaud C, Levi F, Focan C, Touitou Y, Bouvenot G. Physiopathological alterations of alpha 1 acid glycoprotein temporal variations: implications for chronopharmacology. Alpha 1 Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology, P Baumann. Alan R Liss, Inc., New York 1989; 199–214
   Google Scholar
• Bruguerolle B, Bouvenot G, Bartolin R, Pouyet A. Chronokinetics of acetaminophen in elderly patients. Annu. Rev. Chronopharmacol. 1990; 7: 265–268
   Google Scholar
• Clench J, Reinberg A, Dziewanowska Z, Ghata J, Smolensky M. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur. J. Clin. Pharmacol. 1981; 20: 359–369
   PubMed Web of Science ®Google Scholar
• Davis B, Sadik K. Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy. Dement. Geriatr. Cogn. Disord. 2006; 21: 120–129
   PubMed Web of Science ®Google Scholar
• Fuchs W S, Weiss G, Von Nieciecki A, Laicher A, Gay S, Pabst G, Muller M. Pharmacokinetics of a new fluid theophylline sustained‐release drug form. Microcapsules as a sachet. Arzneimittelforschung 1998; 48: 612–617
   PubMed Web of Science ®Google Scholar
• Fujimura A, Ohira H, Shiga T, Ohashi K, Ebihara A. Chronopharmacology of furosemide in the elderly. J.Clin. Pharmacol. 1992; 32: 838–842
   PubMed Web of Science ®Google Scholar
• Hermida R C. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: Rational and design of the MAPEC study. Chronobiol. Int. 2007; 24: 749–775
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Dominínguez M J, Covelo M, Fernández J R, Fontao M J, López J E. Administration‐time‐dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol. Int. 2004; 21: 277–296
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, Mojón A, Rodríguez M, Chayán L, López J E, Fontao M J, Soler R, Fernández J R. Administration time‐dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol. Int. 2005; 22: 755–776
   PubMed Web of Science ®Google Scholar
• Hermida R C, Calvo C, Ayala D E, López J E, Rodríguez M, Chayán L, Mojón A, Fontao M J, Fernández J R. Dose and administration‐time‐dependent effects of nifedipine GITS on ambulatory blood pressure in hypertension subjects. Chronobiol. Int. 2007; 24: 471–493
   PubMed Web of Science ®Google Scholar
• Kinirons M, Crome P. Clinical pharmacokinetic considerations in the elderly. Clin. Pharmacokinet. 1997; 33: 302–312
   PubMed Web of Science ®Google Scholar
• Langner B, Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Eur. J. Clin. Pharmacol. 1988; 33: 619–624
   PubMed Web of Science ®Google Scholar
• Lemmer B. The clinical relevance of chronopharmacology in therapeutics. Pharmacol Res. 1996; 33: 107–115
   PubMed Web of Science ®Google Scholar
• Lemmer B. Chronopharmacology and controlled drug release. Expert Opin. Drug Deliv. 2005; 2: 667–681
   PubMedGoogle Scholar
• Levi F, Schibler U. Circadian rhythms: Mechanisms and therapeutic applications. Ann. Rev. Pharmacol. Toxicol. 2007; 47: 593–628
   PubMed Web of Science ®Google Scholar
• Reinberg A. Concepts in chronopharmacology. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 51–66
   PubMed Web of Science ®Google Scholar
• Rodgers A, Bateman D N, Woodhouse K W. Diurnal variation in absorption of slow‐release aminophylline in the elderly. Eur. J. Pharmacol. 1988; 33: 593–597
   Web of Science ®Google Scholar
• Shiga T, Fujimura A, Tateishi T, Ohashi K, Ebihara A. The effect of age on diurnal variation in the pharmacokinetics of propranolol in hypertensive subjects. Eur. J. Clin. Pharmacol. 1993; 44: 489–492
   PubMed Web of Science ®Google Scholar
• Smolensky M H. Aspects of human chronopathology. Biological Rhythms and Medicine. Cellular, Metabolic, Physiopathologic and Pharmacologic Aspects, A Reinberg, M H Smolensky. Springer Verlag, Heidelberg 1983; 131–209
   Google Scholar
• Smolensky M H, Peppas N. Chronobiology, drug delivery and chronotherapeutics. Adv. Drug. Deliv. Rev., M H Smolensky, N Peppas, 2007; 59: 823–851
   Google Scholar
• Smolensky M H, Reinberg A E, Martin R J, Haus E. Clinical chronobiology and chronotherapeutics with applications to asthma. Chronobiol Int. 1999; 16: 539–563
   PubMed Web of Science ®Google Scholar
• Smolensky M H, Lemmer B, Reinberg A. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv. Drug. Deliv. Rev. 2007; 59: 852–882
   PubMed Web of Science ®Google Scholar
• Srinivas N R, Shyu W C, Gleason C, Schuster A, Greene D S, Barbhaiya R H. Effects of age, gender, and diurnal variation on the steady‐state pharmacokinetics of BMS‐181101, an antidepressant, in healthy subjects. Clin. Pharmacol. Ther. 1997; 62: 408–416
   PubMed Web of Science ®Google Scholar
• Touitou Y. The aging of biological rhythms in man. Pathol. Biol. (Paris). 1987; 35: 1005–1012
   PubMedGoogle Scholar
• Touitou Y, Touitou C, Bogdan A, Reinberg A, Auzeby A, Beck H, Guillet P. Circadian and circannual variations in plasma proteins. Clin. Chem. 1986; 32: 801–804
   PubMed Web of Science ®Google Scholar
• Touitou Y, Bogdan A, Haus E, Touitou C. Modifications of circadian and circannual rhythms with aging. Exp. Gerontol. 1997; 32: 603–614
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky M, Portaluppi F. Ethics, standards and procedures of animal and human chronobiology research. Chronobiol. Int. 2006; 23: 1083–1096
   PubMed Web of Science ®Google Scholar
• Tumer N, Scarpace P J, Lowenthal D T. Geriatric pharmacology: Basic and clinical considerations. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 271–302
   PubMed Web of Science ®Google Scholar
• Willis G L, Turner E J. Primary and secondary features of Parkinson's disease improve with the strategic exposure to bright light: A case series study. Chronobiol. Int. 2007; 23: 521–537
   Google Scholar